trial · primary record
Bone Marrow Aspiration
Recurrent Ganglioneuroblastoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 76 |
| Primary completion | 2029-09-30 |
| Primary endpoint | Recommended phase 2 dose (Phase 1) |
| Registry ID | NCT07437963 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.078Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07437963
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.